Skip to main content

Table 2 Sensitivity rate of Acinetobacter baumannii isolated from sputum and BALF to commonly used antibiotics

From: Pathogenic characteristics of sputum and bronchoalveolar lavage fluid samples from patients with lower respiratory tract infection in a large teaching hospital in China: a retrospective study

Antibiotics

2013–2015

2016–2018

BALF

sputum

P

BALF

sputum

P

Piperacillin

25.8

7.9

P < 0.01

2.2

2.3

P > 0.05

Cefoperazone/sulbactam

14.1

17.8

P > 0.05

9.3

6.1

0.01 < P < 0.05

Ampicillin/sulbactam

14.2

16.7

P > 0.05

9.3

5.7

0.01 < P < 0.05

Piperacillin/tazobactam

32.1

14.8

P < 0.01

7.1

4

0.01 < P < 0.05

Ceftazidime

27.1

8.4

P < 0.01

4.8

3.1

P > 0.05

Cefepime

32.1

16.6

P < 0.01

9

5.2

P < 0.01

Aztreonam

0.6

1.5

P > 0.05

0.6

0.2

P > 0.05

Imipenem

11

16.9

P > 0.05

9.6

5.5

P < 0.01

Meropenem

10.9

15.8

P > 005

9.3

5

P < 0.01

Amikacin

12.8

21.4

0.01 < P < 0.05

14.7

10

0.01 < P < 0.05

Gentamicin

9.6

14.8

P > 0.05

9.6

5.5

P < 0.01

Tobramycin

10.9

18.1

0.01 < P < 0.05

12.8

7.5

P < 0.01

Ciprofloxacin

15.4

17.4

P > 0.05

8.3

4.7

P < 0.01

Levofloxacin

31.4

18.2

P < 0.01

9

5

P < 0.01

Trimethoprim sulfamethoxazole

33.3

16.7

P < 0.01

10.3

6.7

0.01 < P < 0.05

Minocycline

38.7

33.8

P > 0.05

33.4

35.3

P > 0.05

Tegacycline

34.8

46.3

P < 0.01

43.4

46.4

P > 0.05